Bio-Rad Laboratories (BIO) Earnings Date, Estimates & Call Transcripts $318.04 +1.81 (+0.57%) (As of 09:34 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Earnings SummaryUpcoming Earnings DateOct. 24EstimatedActual EPS (Aug. 1) $3.11 Beat By $0.99 Consensus EPS (Aug. 1) $2.12 Conference Call TranscriptConference Call AudioEarnings Press Release Get Bio-Rad Laboratories Earnings AlertsEnter your email address below to receive the latest news and earnings results for BIO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueBIO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BIO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Angel PublishingWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment for as much as $7,882 — each quarter.Discover how to receive your FIRST "Stimulus Stipends" payment for up to $7,882 here. Bio-Rad Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$2.06$2.06$2.06 Q2 20241$2.03$2.03$2.03 Q3 20241$2.70$2.70$2.70 Q4 20241$3.39$3.39$3.39 FY 20244$10.18$10.18$10.18 Q1 20251$2.40$2.40$2.40 Q2 20251$2.63$2.63$2.63 Q3 20251$3.44$3.44$3.44 Q4 20251$2.99$2.99$2.99 FY 20254$11.46$11.46$11.46 Q1 20261$3.18$3.18$3.18 BIO Earnings Date and InformationBio-Rad Laboratories last issued its quarterly earnings results on August 1st, 2024. The medical research company reported $3.11 earnings per share for the quarter, beating analysts' consensus estimates of $2.12 by $0.99. The firm earned $638.50 million during the quarter, compared to analyst estimates of $645.79 million. Its revenue was down 6.3% compared to the same quarter last year. Bio-Rad Laboratories has generated ($10.36) earnings per share over the last year (($10.36) diluted earnings per share). Earnings for Bio-Rad Laboratories are expected to grow by 8.80% in the coming year, from $10.80 to $11.75 per share. Bio-Rad Laboratories has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 24th, 2024 based off prior year's report dates.Read More Bio-Rad Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 10/24/2024(Estimated)------- 8/1/2024Q2 2024$2.12$3.11+$0.99$82.48$645.79 million$638.50 million 5/7/2024Q1 2024$2.04$2.29+$0.25($8.87)$619.09 million$610.82 million 2/15/2024Q4 2023$2.93$3.10+$0.17($5.94)$685.00 million$681.18 million 10/26/2023Q3 2023$2.87$2.33($0.54)$1.02$689.50 million$632.10 million 8/3/2023Q2 2023$2.55$3.00+$0.45$45.59$697.96 million$681.10 million 5/4/2023Q1 2023$3.24$3.34+$0.10$4.36$689.28 million$676.80 million Get the Latest News and Ratings for BIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter. 2/16/2023Q4 2022$3.45$3.31($0.14)($21.16)$741.01 million$730.29 million 10/27/2022Q3 2022$2.59$2.60+$0.01$10.72$685.50 million$680.10 million 7/28/2022Q2 2022$2.46$3.38+$0.92$37.88$664.60 million$691.10 million 4/28/2022Q1 2022$2.80$4.94+$2.14$122.45$678.00 million$700.10 million 2/10/2022Q4 2021$2.87$3.21+$0.34$59.01$731.94 million$732.80 million 10/28/2021Q3 2021$2.30$3.71+$1.41($122.54)$670.36 million$747.00 million 7/28/2021Q2 2021$2.66$3.54+$0.88($23.24)$610.40 million$715.93 million 4/29/2021Q1 2021$2.50$5.21+$2.71($21.96)$661.00 million$726.80 million 2/10/2021Q4 2020$3.30$4.01+$0.71($19.79)$681.80 million$789.84 million 10/29/2020Q3 2020$1.85$3.00+$1.15($37.64)$567.35 million$647.26 million 7/30/2020Q2 2020$1.22$1.61+$0.39($28.93)$526.80 million$536.88 million 5/6/2020Q1 2020$1.57$1.91+$0.34($18.90)$545.70 million$571.60 million 2/13/2020Q4 2019$2.44$2.32($0.12)($13.67)$636.50 million$624.43 million 10/31/2019Q3$1.36$1.61+$0.25$11.90$561.40 million$560.60 million Bio-Rad Laboratories Earnings - Frequently Asked Questions When is Bio-Rad Laboratories's earnings date? Bio-Rad Laboratories has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 24th, 2024 based off last year's report dates. Learn more on BIO's earnings history. What guidance has Bio-Rad Laboratories issued on next quarter's earnings? Bio-Rad Laboratories issued an update on its FY 2024 earnings guidance on Thursday, August, 1st. The company issued revenue guidance of $2.6 billion-$2.6 billion, compared to the consensus revenue estimate of $2.7 billion. Did Bio-Rad Laboratories beat their earnings estimates last quarter? In the previous quarter, Bio-Rad Laboratories (NYSE:BIO) reported $3.11 earnings per share (EPS) to beat the analysts' consensus estimate of $2.12 by $0.99. Learn more on analysts' earnings estimate vs. BIO's actual earnings. How can I listen to Bio-Rad Laboratories's earnings conference call? The conference call for Bio-Rad Laboratories's latest earnings report can be listened to online. Listen to Conference Call How can I read Bio-Rad Laboratories's conference call transcript? The conference call transcript for Bio-Rad Laboratories's latest earnings report can be read online. Read Transcript How much revenue does Bio-Rad Laboratories generate each year? Bio-Rad Laboratories (NYSE:BIO) has a recorded annual revenue of $2.56 billion. How much profit does Bio-Rad Laboratories generate each year? Bio-Rad Laboratories (NYSE:BIO) has a recorded net income of -$637.32 million. BIO has generated -$10.36 earnings per share over the last four quarters. What is Bio-Rad Laboratories's EPS forecast for next year? Bio-Rad Laboratories's earnings are expected to grow from $10.80 per share to $11.75 per share in the next year, which is a 8.80% increase. More Earnings Resources from MarketBeat Related Companies: MTD Earnings ILMN Earnings WAT Earnings TECH Earnings CRL Earnings BRKR Earnings PACB Earnings HBIO Earnings TMO Earnings A Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Target Hits the Mark: Q2 Earnings Exceed ExpectationsModerna Dips on Q2 Earnings But Can It Rip on a Short Squeeze?Doximity: The 'Facebook for Doctors' Surges After Earnings BeatDeere Rebounds on Earnings Beat, But Uphill Battle RemainsWhy You Shouldn't Count Out Tencent Music Stock After EarningsHut 8 Corp.’s Earnings: Is Crypto Mining About to Change?Is NVIDIA Stock a Buy Ahead of Earnings? This page (NYSE:BIO) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredTrump is sounding the alarmEurope is one of the latest to release a central bank digital currency and along with it, new cash rules. Chri...Preserve Gold | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredUS developing “superweapon” to defeat China and Russia?Our new superweapon is a gift to every patriot. I predict the devastating new tech behind this weapon will cre...Paradigm Press | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredSilver Grab of the Decade?In a groundbreaking move, J.P. Morgan now possesses the largest amount of physical silver in recorded history…...Colonial Metals | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
